MiMedx Group/MDXG

$8.63

5.75%
-
1D1W1MYTD1YMAX

About MiMedx Group

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. The Company is focused on addressing unmet clinical needs in the areas of Advanced Wound Care, Surgical Recovery, and osteoarthritis. The Company operates through two segments: Wound and Surgical, and Regenerative Medicine. The Wound and Surgical segment focuses on the Advanced Wound Care and Surgical Recovery markets. Its platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc. The Regenerative Medicine segment focuses solely on Regenerative Medicine technologies. The Company’s product portfolio and pipeline include EPIFIX, AMNIOFIX, mDHACM, AMNIOBURN, EPICORD and AMNIOCORD, AXIOFILL, and AMNIOEFFECT.

Ticker

MDXG

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Joseph Capper

Employees

867

Headquarters

Marietta, United States
Website
mimedx.com

MiMedx Group Metrics

BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$0.02
EPS
1.33
Beta
-
Dividend rate

What the Analysts think about MiMedx Group

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 5 analysts.
46% upside
High $14.00
Low $11.00
$8.63
Current price
$12.60
Average price target

MiMedx Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.4% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$81.7M
0.62%
Net income
$8.5M
608.33%
Profit margin
10.4%
607.48%

MiMedx Group Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 357.14%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.06
-
$0.06
$0.32
-
Expected
-$0.09
-$0.02
$0.05
$0.07
$0.04
Surprise
-30.77%
-
33.33%
357.14%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell MiMedx Group stock

Buy or sell MiMedx Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing